Background We previously reported that children undergoing cardiac surgery are at high risk for long-term chronic kidney disease (CKD) and hypertension, although postoperative acute kidney injury (AKI) is not a risk factor for worse long-term kidney outcomes. We report here our evaluation of renal injury biomarkers 5 years after cardiac surgery to determine whether they are associated with postoperative AKI or long-term CKD and hypertension. Methods Children aged 1 month to 18 years old undergoing cardiopulmonary bypass were recruited to this prospective cohort study. At 5 years after cardiac surgery, we measured urine interleukin-18, kidney injury molecule-1, monocyte chemoattractant protein-1, YKL-40, and neutrophil gelatinase-associated lipocalin (NGAL). Biomarker levels were compared between patients with AKI and those without. We also performed a cross-sectional analysis of the association between these biomarkers with CKD and hypertension. Results Of the 305 subjects who survived hospitalization, four (1.3%) died after discharge, and 110 (36%) participated in the 5-year follow-up. Of these 110 patients, 49 (45%) had AKI. Patients with versus those without postoperative AKI did not have significantly different biomarker concentrations at 5 years after cardiac surgery. None of the biomarker concentrations were associated with CKD or hypertension at 5 years of follow-up, although CKD and hypertension were associated with a higher proportion of participants with abnormal NGAL levels. Conclusions Postoperative pediatric AKI is not associated with urinary kidney injury biomarkers 5 years after surgery. This may represent a lack of chronic renal injury after AKI, imprecise estimation of the glomerular filtration rate, the need for longer followup to detect chronic renal damage, or that our studied biomarkers are inadequate for evaluating subclinical chronic renal injury.
Introduction
Pediatric acute kidney injury (AKI) is common after cardiac surgery and is associated with increased inpatient mortality, length of ventilation, and length of hospital stay [1, 2] . However, much less is known about the long-term outcomes after AKI in children [3, 4] . We previously reported that hypertension and chronic kidney disease (CKD) were common in children 5 years after undergoing cardiac surgery, although postoperative AKI was not associated with an increased risk of long-term kidney outcomes [5] . Likewise, Cooper et al. found that 7 years after cardiac surgery there was no association of AKI with CKD, but that patients with AKI had an elevation of urine kidney injury biomarkers at follow-up [6] . Most recently, a retrospective study evaluating administrative data from Denmark found that children with AKI after cardiac surgery are 3.8-fold more likely to develop CKD [7] . Research findings in adult cohorts have clearly demonstrated the association between AKI and risk of long-term CKD, in multiple settings, including cardiac surgery [8, 9] .
One of the explanations for the conflicting findings on AKI outcomes in the pediatric literature may be the limitations of our current CKD biomarkers, serum creatinine and proteinuria. Proteinuria and serum creatinine may increase late in the course of CKD [10] . In addition, up to 50% of renal mass may be lost without any change in serum creatinine levels, due to compensatory glomerular hypertrophy and hyperfiltration [11] . Therefore, the serum creatinine level may go unchanged for years in children with CKD [12] . Additionally, serum creatinine is a marker of glomerular filtration and is not specific for identifying tubular or interstitial damage. Proteinuria has up to a 40% intraday variability and is often absent in patients with CKD [10] . Thus, there is clearly a need for more sensitive and predictive biomarkers to study patients at risk for CKD.
A number of novel urinary biomarkers have been studied as candidate proteins of chronic kidney injury, primarily in adults [6, 13, 14] . Thee levels of these urinary biomarkers may rise earlier than serum creatinine and therefore may be used for the early prediction of incident CKD or CKD progression. Additionally, novel biomarkers may capture the variability in CKD progression left unexplained by serum creatinine and proteinuria. Since CKD is a multifactorial disease process we measured a biomarker panel in children 5 years after cardiac surgery that assessed tubular injury (interleukin-18 , kidney injury molecule-1 [KIM-1], neutrophil gelatinase-associated lipocalin [NGAL]), inflammation/ repair (monocyte chemoattractant protein-1 [MCP-1]), and fibrosis/repair (YKL-40). There is pre-clinical or human research to suggest that all five of these candidate biomarkers may detect late kidney injury and CKD [15] [16] [17] [18] [19] [20] [21] . We measured two biomarkers, MCP-1 and YKL-40, for the first time in this cohort at 5 years of follow-up because they are candidate biomarkers of renal repair after injury [21] [22] [23] . The primary goal of the study reported here was to determine if AKI after cardiac surgery is associated with long-term evidence of subclinical kidney injury, detected using novel biomarkers. We hypothesized that children with at least stage I AKI would have higher 5-year urinary biomarker levels than children without AKI. We also evaluated the extent to which biomarkers (indexed and not indexed to urine creatinine or when expressed as abnormal using gender-and age-specific threshold values) and the change in biomarker concentrations from preoperative to the end of the 5-year follow-up are associated with 5-year CKD or hypertension.
Materials and methods

Study cohort
This is a prospective cohort study of children with congenital heart disease who were enrolled between July 2007 and December 2009. Children 1 month to 18 years old undergoing cardiac surgery with cardiopulmonary bypass at Cincinnati Children's Hospital, Montreal Children's Hospital, and Yale New-Haven Children's Hospital, were enrolled in the Translational Research Investigating Biomarker End Points in AKI (TRIBE-AKI) study [24] [25] [26] . Children were excluded if they had a history of renal transplantation or dialysis. Details around preoperative patient recruitment are published in previous reports [25, 27] . The children who consented to future contact during the index hospitalization were invited to participate in the current study. Informed consent was obtained from parents or legal guardians, along with assent, when appropriate, from children. This study was approved by the institutional review board of each participating institution.
Study visits
In-person visits at 5 years after cardiac surgery were performed by a research nurse at the hospital clinic or at the subject's home as previously described [5] . Height, weight, and blood pressure were measured, and blood and urine were collected at the time of the visits. Percentiles and z-scores of height, weight, and body mass index were calculated using the U.S. Centers for Disease Control and Prevention growth charts. Blood pressure percentiles were calculated as per The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents [28] . During the visit, other details on the medical history, interim hospital admissions, medication history, and laboratory testing since cardiac surgery, were also collected. Discharge summaries from hospital admissions and other medical records were obtained for each hospitalization from the respective medical institutions. Full details of the serum creatinine, urine creatinine, and albuminuria measurements, including sample collection and processing, have been previously described [5] .
Data from the index cardiac surgery admission
The following detailed index cardiac surgery admission information was available in all participants from our prior in-hospital study: preoperative characteristics, operative details, and postoperative complications using the definitions of the Society of Thoracic Surgeons [29] . We utilized the risk adjustment for congenital heart surgery-1 (RACHS-1) consensus-based scoring system to categorize the complexity of surgery [29] . AKI was defined as the development of at least stage one AKI, defined by a ≥ 50% increase or a ≥ 0.3 mg/dL increase from baseline serum creatinine level during hospitalization after cardiac surgery [30] . We also analyzed the outcome of stage two AKI, defined as a doubling in serum creatinine concentration from baseline or receiving acute dialysis during the hospital stay. Details of the in-hospital study have been previously described [24] [25] [26] .
Biomarker measurements
We measured urinary NGAL, IL-18, and KIM-1 preoperatively, on the first postoperative day, and at the 5-year study visit. YKL-40 and MCP-1 were only measured at the 5-year visit due to limited urine volumes. Perioperative NGAL and IL-18 were measured using the ARCHITECT® assay (Abbott Diagnostics, Abbott Park, IL, USA), while KIM-1 was measured using a Sekisui Diagnostics' assay (Sekisui Diagnostics LLC, Stamford, CT, USA). Urine NGAL, IL-18, KIM-1, YKL-40, and MCP-1 concentrations at 5 years after cardiac surgery were measured using a multiplex assay (Meso Scale Diagnostics [MSD] LLC, Rockville, MD, USA) with intraassay coefficients of variation of 2.1, 7.1, 7.6, 1.7, and 1.4%, respectively [25, 26] . This assay uses patterned arrays and an electrochemiluminescence detection method which is quantified using the MSD Quickplex SQ 120 instrument. To evaluate differences between the perioperative and 5-year assays, 75 perioperative samples were re-measured on the MSD platform. The correlation between platforms was excellent (0.90 for IL-18 and 0.89 for KIM-1), but KIM-1 measurements from the MSD assay were systematically lower than those from the Sekisui Diagnostics' assay. Therefore, we did not include preoperative KIM-1 measurements in this study. Five-year biomarkers were primarily expressed as concentrations. For IL-18 and NGAL we also evaluated absolute change in biomarkers (delta) from preoperative to 5-year follow-up concentrations. Biomarker age-and gender-specific abnormal thresholds (cutoffs) were available for urine KIM-1, IL-18, and NGAL. Based on prior published biomarker reference ranges in children, we determined whether 5-year biomarker levels of IL-18, NGAL, and KIM-1 were greater than published age-and gender-specific cutoffs [31] . The 95th percentile biomarker cutoffs by age and gender were used as abnormal biomarker thresholds for NGAL (3-5 years old [yo]: male [M] 26.1 ng/mL, female [F] 52.2 ng/mL; 5-10 yo: M 10.9 ng/mL, F 139.5 ng/mL; 10-15 yo: M 25.5 ng/ mL, F 72.3 ng/mL; 15-18 yo; M 50.0 ng/mL, F 138.6 ng/ mL), IL-18 (3-5 yo: M 78.3 pg/mL, F 100.5 pg/mL; 5-10 yo: M 41.7 pg/mL, F 79.0 pg/mL; 10-15 yo: M 58.5 pg/mL, F 111.1 pg/mL; 15-18 yo: M 71.2 pg/mL, F 273.1 pg/mL), and KIM-1 (3-5 yo: M 983.7 pg/mL, F 1291.7 pg/mL; 5-10 yo: M 1276.6 pg/mL, F 1212.9 pg/mL; 10-15 yo: M 1156.6 pg/ mL, F 1103.5 pg/mL; 15-18 yo: M 1877.3 pg/mL, F 1934.5 pg/mL) [31] .
Five-year outcome definitions: Hypertension and CKD
For participants up to 18 years of age, hypertension was defined as systolic or diastolic blood pressure ≥ 95th percentile for age, gender, and height [28] . For participants aged > 18 years, hypertension was defined as systolic or diastolic blood pressure > 140 or > 90 mmHg, respectively [32] . Additionally, subjects were classified as having hypertension if they reported a history of hypertension. We calculated estimated glomerular filtration rate (eGFR) using the serum creatinine-based eGFR equation and the cystatin C-based eGFR equation of the Chronic Kidney Disease in Children study (CKiD) [33] . Albuminuria was defined as a urine albumin to creatinine ratio > 30 mg/g. CKD was defined as a serum creatinine-based eGFR < 90 ml/min/1.73 m 2 or albuminuria [34] .
Statistical analysis
Baseline characteristics of participants who completed and did not complete follow-up visits were compared. For each outcome, only those participants with non-missing values were included in the analysis. Continuous variables were compared with the two-sample t test or Wilcoxon rank sum test, and dichotomous variables with the chi-squared test or Fisher's exact test. Five-year urine biomarker concentrations were compared between patients with and without postoperative AKI, and multiple linear regression was performed to evaluate this association, adjusting for age, race, gender, RACHS-1, cardiopulmonary bypass time, and study site. Patients with versus without CKD and patients with versus without hypertension were compared for 5-year biomarker concentrations, preoperative to 5-year biomarker concentration change, and presence/absence of elevated biomarkers at 5 years after cardiac surgery. SAS version 9.4 (SAS Institute, Cary NC, USA) was used for analyses.
Results
Study population
Of the 311 children enrolled in the TRIBE-AKI cohort, 305 survived the index hospitalization (Fig. 1 ). Of these, 105 children declined future contact. Of the 200 children eligible for consent, 131 children were included in the 5-year follow-up study. Urine samples available in 110 of these children at a median of 5.4 years of follow-up, and analyses were carried out on these 110 children. Patient baseline and perioperative characteristics by AKI status are shown in Table 1 . Children with postoperative AKI had a higher preoperative eGFR, longer cardiopulmonary bypass time, and a higher RACHS-1 category when compared to children without postoperative AKI. Of the 110 children, 49 (45%) developed AKI after their index cardiac surgery.
Postoperative AKI and five-year biomarkers
The AKI versus non-AKI biomarker concentrations from preoperative, postoperative, and 5-year time points for NGAL, and IL-18 are shown in Fig. 2 
Five-year biomarkers and kidney outcomes
At the 5-year follow-up visit, the median urine albumin to creatinine ratio and serum creatinine-based eGFR in children was 5.1 (interquartile range [IQR] 2.8-12.6) mg/g and 113 (IQR 103-126) mL/min/1.73 m 2 , respectively ( Table 2 ). Hypertension and CKD were present in 20 (18%) and 18 (17%) children, respectively. Five-year median urine IL-18, KIM-1, MCP-1, YKL-40, and NGAL concentrations were not significantly higher in children with versus those without hypertension or CKD at 5 years after cardiac surgery (see Table 3 for hypertension and Table 4 for CKD). The median 5-year urine KIM-1 concentration was lower in patients with CKD (0.3; IQR 0.2-0.6) than in patients without CKD (0.6; IQR 0.3-1.0) (p = 0.04). Similarly, there was no significant difference in absolute change in urine biomarker concentrations (NGAL, IL-18) from preoperative to 5 years after cardiac surgery in patients with versus those without hypertension (Table 3) or CKD (Table 4 ). Both hypertension (vs. no hypertension) and CKD (vs. no CKD) were associated with a higher proportion of patients with 5-year NGAL concentrations above normal for age; they were not associated with abnormal 5-year KIM-1 or IL-18 concentrations (Tables 3 and 4 ). There was no change in our 5-year biomarker results in patients with or without CKD when we used a cystatin C-based equation to estimate GFR (data not shown). Additionally, the lack of association with AKI, CKD, and hypertension remained unaffected when we adjusted 5-year biomarker concentrations for urinary creatinine (ESM Tables 2, 3 , and 4).
Discussion
This is the largest prospective study to examine the association between postoperative AKI and long-term kidney injury biomarkers in children who underwent cardiopulmonary bypass. We found that postoperative AKI was not associated with later elevations of urine biomarkers of kidney injury and that children with 5-year CKD and hypertension did not generally have higher kidney biomarkers at follow-up.
A previous study by Cooper et al. found that children with AKI after cardiac surgery had significantly higher levels of IL-18, KIM-1, and L-type fatty acid binding protein (L-FABP) at approximately 7 years after cardiac surgery compared to children without AKI [6] . These findings suggested that despite a lack of association of AKI with later CKD, there may have been ongoing subclinical kidney injury in the long term that was only Fig. 1 Flow chart of study population in the TRIBE-AKI long-term follow-up study detectable by more sensitive urine kidney injury biomarkers. Several differences between our study and the Cooper study may explain our differing findings. The Cooper study had a smaller sample size (n = 51) from a single center, but was enriched with patients who developed severe AKI (postoperative doubling of serum creatinine). However, when we evaluated patients with stage two AKI or worse, we did not find an association between more severe AKI and 5-year biomarker concentrations. The follow-up in the Cooper et al. study, with a median of 7 years, was longer than that in our study; it is thus conceivable that patients in their cohort had more time to develop differential biomarker concentrations between AKI groups over time. Finally, patient characteristics between the two studies also differed, with the Cooper et al. study including neonates at the time of surgery, longer cardiopulmonary bypass time, and higher RACHS-1 scores, all of which may have placed them at overall increased risk for long-term subclinical renal damage [35] . However, when we performed a multivariable regression analysis and controlled for potential confounders, there was still no association with AKI and 5-year biomarkers. Importantly, biomarker concentrations were quite different between the two cohorts and were measured with different assays, which lends to even more difficulties in comparing the two studies. Our study Values are presented as a number with the percentage in parenthesis, the mean with the standard deviation (SD) in parenthesis, or as the median with the interquartile range (IQR) in square brackets AKI, Acute kidney injury; CPB, cardiopulmonary bypass; GFR, glomerular filtration rate (mL/min/1.73 m 2 ); ICU, intensive care unit; SCr, serum creatinine (in mg/dL. 1 mg/dL = 88.4 μmole/L); RACHS-1, risk adjustment for congenital heart surgery that AKI leads to long-term subclinical renal injury, as evidenced by elevated kidney injury biomarkers; however, it also highlights the importance of validating biomarker studies in larger cohorts from multiple centers. We evaluated the cross-sectional association between 5-year urine biomarkers and the presence of functional kidney abnormalities or hypertension, with the rationale that if urine injury biomarkers were in fact indicative of chronic injury in this clinical context, they should be higher in patients with functional impairment. Overall, the utility of renal injury biomarkers in evaluating subclinical chronic kidney injury is still an active area of investigation; thus, negative findings are as important as positive findings [15, 16, 18-20, 36, 37] . Biomarker concentrations were not significantly different in our cohort of children with (vs. without) CKD or hypertension. Although it is intriguing that children with hypertension and those with CKD had a higher prevalence of abnormally high urine NGAL, these results must be interpreted with caution, given the multiple testing performed in our study and the risk of spurious results. That said, several previous studies in patients with CKD associated with other diseases have also found that urine NGAL is associated with worse renal function [37, 38] . It is thus worth evaluating in future research the utility of abnormal NGAL levels to screen for and predict progression of renal disease after cardiac surgery. We found at the 5-year visit, urine KIM-1 was lower in children with CKD than in those without CKD. Since KIM-1 is a tubular protein detected with kidney injury, this association is not supported by previous KIM-1 research and may be influenced by confounding factors [17, 39, 40] . Our overall lack of association of urine injury biomarkers with CKD or with hypertension may also be explained by other issues. It is possible that our studied biomarkers are not sufficiently sensitive to detect renal damage in the nonacute setting in patients after cardiac surgery. Secondly, it is possible that our methods of evaluating renal disease (CKD and hypertension) are non-specific to chronic tubular injuryassociated renal disease in the cardiac surgery population; other factors (e.g., hormonal, humoral, vascular, cardiac) which are not related to these kidney injury biomarkers may play a more important role in the renal disease pathophysiology. Thus, while our negative findings are relevant in directing future studies in pediatric cardiac surgery longterm outcomes research, they should be evaluated separately in distinct populations (e.g., nephrotoxic AKI or non-cardiac surgery critical illness-associated AKI).
Our study has important limitations. We did not enroll infants younger than 1 month old and thereby excluded many of the infants with the most complex cardiac disease. Due to the substantial limitations of serum creatinine measurements as well as of the pediatric AKI and CKD definitions available, there may have been misclassification of exposure status and outcomes. Importantly, we used an equation to estimate GFR which has not been validated in healthy children without CKD. Additionally, this pediatric cohort may have been sub-optimal to study CKD after AKI as many of our patients had nonprogressive mild AKI, which may not lead to long-term kidney damage in children. Given this uncertainty, future research should consider focusing on severe AKI as a risk factor for CKD. There were a large number of children who declined participation in this long-term follow-up study, although baseline characteristics were not different between those who did and those who did not participate [5] . When we determined the absolute change in urine biomarker concentrations we used different biomarker assays at the perioperative and 5-year time point, although we measured inter-assay variability. Future prospective studies measuring the change of biomarkers in serial biospecimens should make an effort to use identical biomarker assays. There was also a wide age range at study enrollment and the temporal change of urinary biomarkers over 5 years may be influenced by substantial age-related changes in biomarker concentrations over time [31, 41] .
We have previously shown that children undergoing cardiac surgery are at very high risk for long-term CKD and hypertension; however, we did not find an association of AKI with CKD or hypertension development, and the current study does not support the existence of a relationship between urine injury biomarkers and long-term post-cardiac surgery CKD or hypertension. Future research should determine which renal injury biomarkers detect the presence of renal disease or of hypertension in the unique and high-risk cardiac surgery population, while accounting for effects of age and other patient and disease characteristics on determining biomarker concentrations. Future research should also determine the extent to which our studied biomarkers are (or are not) predictive of post-AKI development of CKD or hypertension in other, non-cardiac surgery, populations, in order to guide future AKI outcome translational research. Such research may identify markers of early subclinical renal injury to allow intervention prior to the development of renal functional decline or cardiovascular effects of hypertension. 
